IRMD vs. SRTS
Compare and contrast key facts about IRadimed Corporation (IRMD) and Sensus Healthcare, Inc. (SRTS).
Performance
IRMD vs. SRTS - Performance Comparison
Loading graphics...
IRMD vs. SRTS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IRMD IRadimed Corporation | -0.86% | 79.69% | 16.99% | 75.37% | -37.53% | 102.68% | -2.48% | -4.42% | 61.45% | 36.49% |
SRTS Sensus Healthcare, Inc. | -0.00% | -42.49% | 193.22% | -68.19% | 2.77% | 87.05% | 9.04% | -52.23% | 43.60% | -1.71% |
Fundamentals
IRMD:
$1.24B
SRTS:
$64.98M
IRMD:
$1.75
SRTS:
-$0.47
IRMD:
14.76
SRTS:
2.36
IRMD:
13.10
SRTS:
1.35
IRMD:
$83.81M
SRTS:
$27.48M
IRMD:
$64.32M
SRTS:
$11.87M
IRMD:
$28.93M
SRTS:
-$6.71M
Returns By Period
IRMD
- 1D
- 1.38%
- 1M
- -7.02%
- YTD
- -0.86%
- 6M
- 36.51%
- 1Y
- 86.13%
- 3Y*
- 36.61%
- 5Y*
- 33.35%
- 10Y*
- 18.48%
SRTS
- 1D
- 2.84%
- 1M
- -3.16%
- YTD
- -0.00%
- 6M
- 26.75%
- 1Y
- -15.86%
- 3Y*
- -8.59%
- 5Y*
- 0.67%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IRMD vs. SRTS — Risk / Return Rank
IRMD
SRTS
IRMD vs. SRTS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for IRadimed Corporation (IRMD) and Sensus Healthcare, Inc. (SRTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IRMD | SRTS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.38 | -0.22 | +2.60 |
Sortino ratioReturn per unit of downside risk | 3.53 | 0.20 | +3.34 |
Omega ratioGain probability vs. loss probability | 1.43 | 1.03 | +0.40 |
Calmar ratioReturn relative to maximum drawdown | 8.94 | -0.37 | +9.30 |
Martin ratioReturn relative to average drawdown | 23.02 | -0.61 | +23.63 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| IRMD | SRTS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.38 | -0.22 | +2.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.77 | 0.01 | +0.76 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.44 | -0.05 | +0.50 |
Correlation
The correlation between IRMD and SRTS is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
IRMD vs. SRTS - Dividend Comparison
IRMD's dividend yield for the trailing twelve months is around 1.26%, while SRTS has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
IRMD IRadimed Corporation | 1.26% | 1.21% | 0.82% | 3.54% | 3.53% |
SRTS Sensus Healthcare, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
IRMD vs. SRTS - Drawdown Comparison
The maximum IRMD drawdown since its inception was -75.83%, smaller than the maximum SRTS drawdown of -87.51%. Use the drawdown chart below to compare losses from any high point for IRMD and SRTS.
Loading graphics...
Drawdown Indicators
| IRMD | SRTS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.83% | -87.51% | +11.68% |
Max Drawdown (1Y)Largest decline over 1 year | -9.67% | -45.31% | +35.64% |
Max Drawdown (5Y)Largest decline over 5 years | -49.38% | -87.51% | +38.13% |
Max Drawdown (10Y)Largest decline over 10 years | -64.30% | — | — |
Current DrawdownCurrent decline from peak | -8.42% | -73.41% | +64.99% |
Average DrawdownAverage peak-to-trough decline | -28.29% | -46.09% | +17.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.75% | 27.19% | -23.44% |
Volatility
IRMD vs. SRTS - Volatility Comparison
The current volatility for IRadimed Corporation (IRMD) is 8.66%, while Sensus Healthcare, Inc. (SRTS) has a volatility of 15.01%. This indicates that IRMD experiences smaller price fluctuations and is considered to be less risky than SRTS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| IRMD | SRTS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.66% | 15.01% | -6.35% |
Volatility (6M)Calculated over the trailing 6-month period | 22.94% | 49.16% | -26.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.39% | 71.98% | -35.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.64% | 81.57% | -37.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.46% | 73.47% | -24.01% |
Financials
IRMD vs. SRTS - Financials Comparison
This section allows you to compare key financial metrics between IRadimed Corporation and Sensus Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
IRMD vs. SRTS - Profitability Comparison
IRMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, IRadimed Corporation reported a gross profit of 17.03M and revenue of 22.69M. Therefore, the gross margin over that period was 75.1%.
SRTS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Sensus Healthcare, Inc. reported a gross profit of 1.90M and revenue of 4.94M. Therefore, the gross margin over that period was 38.4%.
IRMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, IRadimed Corporation reported an operating income of 7.09M and revenue of 22.69M, resulting in an operating margin of 31.3%.
SRTS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Sensus Healthcare, Inc. reported an operating income of -3.15M and revenue of 4.94M, resulting in an operating margin of -63.8%.
IRMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, IRadimed Corporation reported a net income of 6.44M and revenue of 22.69M, resulting in a net margin of 28.4%.
SRTS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Sensus Healthcare, Inc. reported a net income of -3.17M and revenue of 4.94M, resulting in a net margin of -64.1%.